Key facts
- Notable investors include Cowin Capital, IDG Capital, Tencent Investment, Alwin Capital, National Innovation Center for Advanced Medical Devices.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for ConceMed
- ·The full record, as it builds
Funding rounds
No funding rounds for ConceMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ConceMed
Developer and producer of gastroenterology soft electronic endoscope products designed to provide clinical users with the best diagnostic and therapeutic solutions. The company's products are digestive endoscopes, like upper gastrointestinal electronic endoscopes, lower gastrointestinal electronic endoscopes, medical endoscope image processors, medical cold light sources and supporting peripheral products, enabling healthcare workers to screen, intervene and treat for digestive tract cancers.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2022
- Website
- concemed.com/
- Ownership
- Privately Held (backing)
ConceMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ConceMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ConceMed in its N-PORT filings yet. We sweep new filings monthly.